J.P. Morgan has initiated coverage of Haemonetics (HAE) with an overweight rating, citing the potential for topline acceleration. Read more here.
Embecta said its patch pump would require additions to be commercially competitive, and plans to use the funds saved to pay down debt.
Guardpack, a UK-based contract manufacturer of wet wipes and sachets, has secured funding that enables expansion into the ...
Donald Trump has named tech investor David Sacks to be “A.I. & Crypto Czar” as a newly created role in his administration ...
A study from PreciseDx showed that its artificial-intelligence-guided pathology test could help predict a patient’s chances ...
New CEOs at RWS, Sorenson, BLEND, and Gridly, Teleperformance acquires ZP, Writer.com raises USD 200m, and new AI ...
Acutus has now tied two large layoffs to the Medtronic partnership. In November 2023, the firm cut about 160 people to focus ...
Field Medical announced today that it received FDA breakthrough device designation for its FieldForce pulsed field ablation ...
Micro-X's 70% climb this week proves momentum is returning to the ASX healthcare sector, notes Morgan analyst Scott Power.
The Emergency Care Research Institute (ECRI) offered tips for medtech firms to prevent harm from artificial intelligence and ...
Envera Systems wants to strengthen its foothold in Tampa Bay with a new sales hub, driving innovation, job creation and ...
The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the ...